Prospective Study of Arthrodesis of Finger Distal Interphalangeal Joints Using the Kerifuse Device (KF23)

February 11, 2025 updated by: Clinique Saint François, Nice, France

Prospective Study of Arthrodesis of Finger Distal Interphalangeal Joints Using the Kerifuse Device KF 23)

Arthrodesis of a distal interphalangeal joint of the finger (DIP) is mainly performed for a degenerated and painful joint. Various stabilization methods have been used to provide compression at the arthrodesis site such as pins, steel wires, compression screws, headless compression screws, bioresorbable implants and intramedullary staples.

Although with complications such as implant fractures or dorsal cortical erosion, intramedullary arthrodesis staples provide reliable pain relief and a consistent fusion rate while inevitably scarring the finger pulp or nail dystrophy.

The aim of this study is to evaluate the bone fusion time during an arthrodesis performed with the Kerifuse shape memory implant.

Study Overview

Status

Recruiting

Detailed Description

Arthrodesis of a distal interphalangeal joint of the finger (DIP) is mainly performed for a degenerated and painful joint. Various stabilization methods have been used to provide compression at the arthrodesis site such as pins, steel wires, compression screws, headless compression screws, bioresorbable implants and intramedullary staples.

Although with complications such as implant fractures or dorsal cortical erosion, intramedullary arthrodesis staples provide reliable pain relief and a consistent fusion rate while inevitably scarring the finger pulp or nail dystrophy.

The aim of this study is to evaluate the bone fusion time during an arthrodesis performed with the Kerifuse shape memory implant.

Main objective is to evaluate the bone fusion time in arthrodesis performed with the Kerifuse shape memory implant.

Secondary objectives are :

  • to evaluate the fusion rate and its associated healing time
  • to evaluate patient satisfaction, including aesthetic aspect
  • to assess overall hand function
  • to evaluate the radiological evolution of the KeriFuse® implant and its implantation site
  • To evaluate the radiological evolution of the arthrodesis angle between the post-operative situation and the final fusion position

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Eligible patients with osteoarthritis of finger for an interphalangeal arthrodesis with KeriFuse implant

Exclusion Criteria:

  • Pregnant or breastfeeding patient
  • Patient with an intellectual disability and who therefore cannot follow the surgeon's instructions
  • Patients with contraindications to surgery
  • Patients with acute or chronic, local or systemic infections
  • Patients with sensitivities or allergies to device components (Nickel, Titanium)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients
Patients older than 18 years-old, with a surgical indication of interphalangeal arthrodesis of finger
The surgery is an arthrodesis of finger or thumb (for patients with finger osteoarthritis) and involves implanting the KeriFuse implant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fusion time of bone in distal interphalangeal arthrodesis of the fingers
Time Frame: day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery
Fusion time of bone (in weeks) will be measure by X-ray,
day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mid-term efficacy of arthrodesis in pain decrease
Time Frame: day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery
Evaluation of pain with analogic visual scale
day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery
Evaluation of arthrosis degree
Time Frame: day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery
Evaluation fo arthrosis degree according to Kellgren-Lawrence scale
day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery
Patient satisfaction
Time Frame: D5 - W4 - W6 - W8 - W10 - W12 - Y2 after surgery
Evaluation of patient satisfaction according to Likert scale
D5 - W4 - W6 - W8 - W10 - W12 - Y2 after surgery
Evaluation of global hand function
Time Frame: day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery
Evaluation by the patient using functional score Quick DASH
day 5 - week 4 - week 6 - week 8 - week 10 - week 12 - year 2 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

November 14, 2023

First Submitted That Met QC Criteria

November 21, 2023

First Posted (Actual)

November 30, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-A02072-43

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis Thumb

Clinical Trials on KeriFuse implant implantation

Subscribe